Recent advances in intranasal liposomes for drug, gene, and vaccine delivery
Liposomes are safe, biocompatible, and biodegradable spherical nanosized vesicles
produced from cholesterol and phospholipids. Recently, liposomes have been widely …
produced from cholesterol and phospholipids. Recently, liposomes have been widely …
Liposomes as delivery systems for nasal vaccination: strategies and outcomes
B Heurtault, B Frisch, F Pons - Expert opinion on drug delivery, 2010 - Taylor & Francis
Importance of the field: Among the particulate systems that have been envisaged in vaccine
delivery, liposomes are very attractive. These phospholipid vesicles can indeed deliver a …
delivery, liposomes are very attractive. These phospholipid vesicles can indeed deliver a …
Liposomal formulations for nose-to-brain delivery: recent advances and future perspectives
SS Hong, KT Oh, HG Choi, SJ Lim - Pharmaceutics, 2019 - mdpi.com
Restricted drug entry to the brain that is closely associated with the existence of the blood
brain barrier (BBB) has limited the accessibility of most potential active therapeutic …
brain barrier (BBB) has limited the accessibility of most potential active therapeutic …
Nose-to-brain/spinal cord delivery kinetics of liposomes with different surface properties
T Kurano, T Kanazawa, A Ooba, Y Masuyama… - Journal of Controlled …, 2022 - Elsevier
The administration of liposomes via nose-to-brain delivery is expected to become a strategy
for efficient drug delivery to the central nervous system. Efficient nose-to-brain delivery and …
for efficient drug delivery to the central nervous system. Efficient nose-to-brain delivery and …
Topical and mucosal liposomes for vaccine delivery
E Lilia Romero, MJ Morilla - Wiley Interdisciplinary Reviews …, 2011 - Wiley Online Library
Mucosal (and in minor extent transcutanous) stimulation can induce local or distant mucosa
secretory IgA. Liposomes and other vesicles as mucosal and transcutaneous adjuvants are …
secretory IgA. Liposomes and other vesicles as mucosal and transcutaneous adjuvants are …
Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations
MM Migliore, TK Vyas, RB Campbell, MM Amiji… - Journal of …, 2010 - Elsevier
The goal of this research was to evaluate the effectiveness of cationic liposomes for
intranasal administration of proteins to the brain. Cationic liposomes were loaded with a …
intranasal administration of proteins to the brain. Cationic liposomes were loaded with a …
Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems
S Sharma, TKS Mukkur, HAE Benson… - Journal of pharmaceutical …, 2009 - Elsevier
The nasal route offers a promising opportunity for the delivery of vaccines. This review
analyses the opportunities and novel delivery strategies based on particulate systems for the …
analyses the opportunities and novel delivery strategies based on particulate systems for the …
Intranasal delivery and transfection of mRNA therapeutics in the brain using cationic liposomes
Nucleic acid-based therapeutics, including the use of messenger RNA (mRNA) as a drug
molecule, has tremendous potential in the treatment of chronic diseases, such as age …
molecule, has tremendous potential in the treatment of chronic diseases, such as age …
Vesicular systems for intranasal drug delivery
IA Alsarra, AY Hamed, FK Alanazi… - Drug delivery to the …, 2010 - Springer
Recently, the nasal route for systemic drug delivery has gained great interest. It provides
several advantages over other routes of drug administrations. These include rapid …
several advantages over other routes of drug administrations. These include rapid …